Matches in Wikidata for { <http://www.wikidata.org/entity/Q93224842> ?p ?o ?g. }
Showing items 1 to 53 of
53
with 100 items per page.
- Q93224842 description "article scientifique publié en 2020" @default.
- Q93224842 description "artículu científicu espublizáu n'abril de 2020" @default.
- Q93224842 description "im April 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q93224842 description "scientific article published on 14 April 2020" @default.
- Q93224842 description "wetenschappelijk artikel" @default.
- Q93224842 description "наукова стаття, опублікована 14 квітня 2020" @default.
- Q93224842 name "G-5555 synergized miR-485-5p to alleviate cisplatin resistance in ovarian cancer cells via Pi3k/Akt signaling pathway" @default.
- Q93224842 name "G-5555 synergized miR-485-5p to alleviate cisplatin resistance in ovarian cancer cells via Pi3k/Akt signaling pathway" @default.
- Q93224842 type Item @default.
- Q93224842 label "G-5555 synergized miR-485-5p to alleviate cisplatin resistance in ovarian cancer cells via Pi3k/Akt signaling pathway" @default.
- Q93224842 label "G-5555 synergized miR-485-5p to alleviate cisplatin resistance in ovarian cancer cells via Pi3k/Akt signaling pathway" @default.
- Q93224842 prefLabel "G-5555 synergized miR-485-5p to alleviate cisplatin resistance in ovarian cancer cells via Pi3k/Akt signaling pathway" @default.
- Q93224842 prefLabel "G-5555 synergized miR-485-5p to alleviate cisplatin resistance in ovarian cancer cells via Pi3k/Akt signaling pathway" @default.
- Q93224842 P1433 Q93224842-05509F4F-E4BE-4DB0-9B83-A1898E5EF454 @default.
- Q93224842 P1476 Q93224842-75F72F7B-9475-42B1-9E71-27BCD89711ED @default.
- Q93224842 P2093 Q93224842-192CC657-0AC7-46FF-90C3-E31FF250CA32 @default.
- Q93224842 P2093 Q93224842-2C834F82-5848-4660-8B04-357D91918E1E @default.
- Q93224842 P2093 Q93224842-481DE8F3-B850-4A14-ADC0-87945382A6F6 @default.
- Q93224842 P2093 Q93224842-5CDDACC0-9FD5-4CB9-BFAE-7B39091B0DD1 @default.
- Q93224842 P2093 Q93224842-5E78C3F8-B6E1-4C54-A9BE-B6C1916BA33B @default.
- Q93224842 P2093 Q93224842-5EDE2F91-9799-46D5-ADF2-6189C0421BF8 @default.
- Q93224842 P2093 Q93224842-6517B0A0-5E82-4A0D-BBDF-FCA620E82C9F @default.
- Q93224842 P2093 Q93224842-D2018844-7F56-4A66-AE2E-5F56DA8A6CCD @default.
- Q93224842 P2093 Q93224842-F9F58184-DBDB-4C79-8509-DD254A01021A @default.
- Q93224842 P304 Q93224842-55FF149A-876A-48E4-A789-F2B7213202C1 @default.
- Q93224842 P31 Q93224842-2F172C85-D9A0-4817-A650-69EFDC00C7EF @default.
- Q93224842 P31 Q93224842-A3C4F290-531A-4508-8A93-F90B98A739B3 @default.
- Q93224842 P356 Q93224842-577E9ED9-C84E-4BC6-9F4D-9E32B3EBF3E5 @default.
- Q93224842 P478 Q93224842-6C6AFE88-DE6A-456A-A846-4F3800B8E403 @default.
- Q93224842 P577 Q93224842-54729CA4-450A-453F-A236-41B6FD3FA5C4 @default.
- Q93224842 P698 Q93224842-58CE7FB6-377B-4ADF-8496-8AC8DE4E3775 @default.
- Q93224842 P921 Q93224842-7CD1F796-8F00-4F17-BCA7-5C6999E5096F @default.
- Q93224842 P356 J.JRI.2020.103129 @default.
- Q93224842 P698 32334286 @default.
- Q93224842 P1433 Q15755932 @default.
- Q93224842 P1476 "G-5555 synergized miR-485-5p to alleviate cisplatin resistance in ovarian cancer cells via Pi3k/Akt signaling pathway" @default.
- Q93224842 P2093 "Feng Shan" @default.
- Q93224842 P2093 "Hai-Feng Qiao" @default.
- Q93224842 P2093 "Jun You" @default.
- Q93224842 P2093 "Lei Du" @default.
- Q93224842 P2093 "Li-Ping Chen" @default.
- Q93224842 P2093 "Man-Hua Liu" @default.
- Q93224842 P2093 "Xiao-Yan Lu" @default.
- Q93224842 P2093 "Yan-Li Zheng" @default.
- Q93224842 P2093 "Ying-Lei Liu" @default.
- Q93224842 P304 "103129" @default.
- Q93224842 P31 Q13442814 @default.
- Q93224842 P31 Q45182324 @default.
- Q93224842 P356 "10.1016/J.JRI.2020.103129" @default.
- Q93224842 P478 "140" @default.
- Q93224842 P577 "2020-04-14T00:00:00Z" @default.
- Q93224842 P698 "32334286" @default.
- Q93224842 P921 Q172341 @default.